↓ Skip to main content

Felbamate as an add-on therapy for refractory epilepsy

Overview of attention for article published in Cochrane database of systematic reviews, July 2014
Altmetric Badge

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
38 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Felbamate as an add-on therapy for refractory epilepsy
Published in
Cochrane database of systematic reviews, July 2014
DOI 10.1002/14651858.cd008295.pub3
Pubmed ID
Authors

Shi LL, Dong J, Ni H, Geng J, Wu T, Shi, Li Li, Dong, JianCheng, Ni, Hengjian, Geng, JinSong, Wu, Taixiang

Abstract

This review is an update of a previously published review in The Cochrane Database of Systematic Reviews (Issue 1, 2011) on 'Felbamate as an add-on therapy for refractory epilepsy'. Epilepsy is a chronic and disabling neurologic disorder, affecting approximately 1% of the population. Up to 30% of people with epilepsy have seizures that are resistant to currently available drugs. Felbamate is one of the second-generation antiepileptic drugs and its effects as an add-on therapy to standard drugs are assessed in this review.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 38 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 16%
Researcher 5 13%
Student > Master 5 13%
Student > Postgraduate 4 11%
Other 3 8%
Other 8 21%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 20 53%
Psychology 3 8%
Nursing and Health Professions 2 5%
Agricultural and Biological Sciences 1 3%
Arts and Humanities 1 3%
Other 1 3%
Unknown 10 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2017.
All research outputs
#17,731,162
of 22,769,322 outputs
Outputs from Cochrane database of systematic reviews
#11,277
of 12,313 outputs
Outputs of similar age
#138,519
of 204,699 outputs
Outputs of similar age from Cochrane database of systematic reviews
#213
of 229 outputs
Altmetric has tracked 22,769,322 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,313 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 204,699 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 229 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.